SNAP-8: Molecular Structure

Molecular Structure and Properties#

SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide with the molecular formula C41H70N16O16S and a molecular weight of 1075.16 Da. The CAS number is 868844-74-0. It was developed by Lipotec S.A.U. (now Lubrizol Life Science) as an enhanced version of the hexapeptide Argireline, with two additional amino acid residues providing improved biological activity.

Amino Acid Sequence#

The complete sequence of SNAP-8 is:

Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2

Or in single-letter code: Ac-EEMQRRAD-NH2

Key structural features:

• N-terminal acetylation (Ac-): Protects against aminopeptidase degradation and mimics the natural N-acetyl group found on mature SNAP-25
• Glutamic acid residues (Glu1, Glu2): Provide negative charges that participate in electrostatic interactions with SNARE complex binding partners
• Methionine (Met3): Contains a thioether group susceptible to oxidation; critical for biological activity
• Glutamine (Gln4): Hydrogen bond donor/acceptor involved in protein-protein interactions
• Arginine residues (Arg5, Arg6): Provide positive charges essential for binding to the SNARE complex; these basic residues mirror the arginine cluster in native SNAP-25
• Alanine (Ala7): Small hydrophobic residue unique to SNAP-8 (not present in Argireline); may improve conformational stability
• Aspartate (Asp8): C-terminal acidic residue unique to SNAP-8; contributes additional electrostatic interactions
• C-terminal amidation (-NH2): Enhances metabolic stability by protecting against carboxypeptidases

The addition of Ala7 and Asp8 distinguishes SNAP-8 from Argireline and is believed to improve binding affinity to the SNARE complex, accounting for the approximately 30% increase in anti-wrinkle activity observed in comparative testing.

Structural Basis for SNARE Complex Inhibition#

SNAP-8's sequence corresponds to the N-terminal region of SNAP-25, which participates in the initial stages of SNARE complex assembly. In native neurotransmitter release:

1. The N-terminal domain of SNAP-25 first associates with syntaxin-1 to form a binary complex
2. VAMP/synaptobrevin on the vesicle membrane then engages to form the ternary SNARE complex
3. The assembled complex generates the mechanical force for vesicle-membrane fusion

SNAP-8 competes with endogenous SNAP-25 at step 1, occupying the syntaxin-1 binding site and preventing formation of a functional binary complex. Because SNAP-8 lacks the remainder of the SNAP-25 sequence, the resulting incomplete complex cannot progress to the ternary stage or generate sufficient force for vesicle fusion.

Physicochemical Properties#

Stability and Formulation#

SNAP-8 demonstrates good stability in aqueous cosmetic formulations:

• pH stability: Stable across pH 5.0-7.0, with optimal stability around pH 5.5-6.0
• Thermal stability: Maintains activity when incorporated into products processed at temperatures up to 40 degrees Celsius; avoid prolonged exposure to elevated temperatures
• Oxidation sensitivity: The methionine residue (Met3) is susceptible to oxidation by peroxides and strong oxidizers present in some cosmetic formulations. Avoid combining with hydrogen peroxide-containing products
• Photostability: Relatively photostable; no significant degradation under normal indoor lighting conditions
• Compatibility: Compatible with most cosmetic ingredients including hyaluronic acid, glycerin, niacinamide, and retinol formulations at appropriate pH

Skin Penetration#

The transdermal delivery of SNAP-8 presents challenges typical of hydrophilic peptides:

• Stratum corneum barrier: The highly lipophilic nature of the outermost skin layer limits passage of hydrophilic molecules like SNAP-8
• Molecular size: At 1075 Da, SNAP-8 exceeds the generally cited 500 Da cutoff for passive transdermal absorption, though this threshold is not absolute
• Partition coefficient: The hydrophilic nature (low log P) of SNAP-8 limits its partitioning into the lipid matrix of the stratum corneum

Research on the related hexapeptide Argireline showed that applied peptide primarily remained in the stratum corneum (0.22% of applied dose), with peptide concentrations decreasing through successive tape strip layers. These findings suggest that while some peptide reaches viable epidermal layers, achieving high concentrations at the dermal neuromuscular junction level remains challenging.

Enhanced delivery strategies under investigation include:

• Microneedle patches: Biodegradable microneedle arrays that bypass the stratum corneum entirely
• Liposomal encapsulation: Lipid vesicles that improve partitioning into the skin lipid matrix
• Penetration enhancers: Chemical agents (ethanol, propylene glycol, oleic acid) that temporarily disrupt stratum corneum barrier function
• Iontophoresis: Electrical current-driven delivery to enhance charged peptide penetration

Analytical Methods#

Quantification of SNAP-8 in cosmetic formulations and biological matrices employs several techniques:

• LC-MS/MS: Liquid chromatography-tandem mass spectrometry provides high sensitivity and specificity for peptide quantification. A validated LC-MS/MS method for acetyl octapeptide-3 has been published using electrospray ionization in positive mode
• HPLC-UV: Reverse-phase HPLC with UV detection at 214-220 nm for routine quality control
• Amino acid analysis: Hydrolysis followed by derivatization and chromatographic analysis for identity confirmation

Related Reading#

• SNAP-8 overview and research guide
• Peptides similar to SNAP-8
• SNAP-8 research evidence